Phase 2a Study of IW-9179 to Treat Functional Dyspepsia

Phase Ⅱc Sutdy of Aolanti Weikang Tablets in FD PDS Patients

NCT03971383 ·Status: UNKNOWN ·Phase: PHASE2

Effect of Itopride, on Symptoms of Functional Dyspepsia, Such as Indigestion, Bloating, Inability to Finish a Meal

NCT00112177 ·Status: COMPLETED ·Phase: PHASE3

Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)

NCT02493452 ·Status: COMPLETED ·Phase: PHASE3

Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D

NCT02239926 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

A Pharmacy-based Observational Study to Learn More About Iberogast Advance in the Real-world Setting

NCT05389709 ·Status: COMPLETED

"Functional Bowel Disorder. Investigation in General Practice"

NCT01153295 ·Status: COMPLETED ·Phase: NA

Effects of a Combination of Polyphenol-rich Extracts, Prebiotics, and Hydrolyzed Fiber on the Quality of Life of Patients With Irritable Bowel Syndrome (IBS)

NCT05990764 ·Status: RECRUITING ·Phase: NA

The Efficacy and Safety of "BST104" (Lonicera Flos Extract) in Mild to Moderate Functional Dyspepsia Subjects

NCT04008901 ·Status: COMPLETED ·Phase: PHASE3

A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)

NCT04129619 ·Status: COMPLETED ·Phase: PHASE2

The FAIS-Trial: Faecal Microbiota Transplantation (FMT) in Adolescents With Refractory Irritable Bowel Syndrome (IBS)

NCT03074227 ·Status: UNKNOWN ·Phase: NA

In Vivo Effects of Amylase Trypsin Inhibitors

NCT05157867 ·Status: UNKNOWN ·Phase: NA

A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS.

NCT00139672 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

NCT01887002 ·Status: TERMINATED ·Phase: PHASE2

Diarrhea Predominant Irritable Bowel Syndrome in Females

NCT00461526 ·Status: COMPLETED ·Phase: PHASE2

Donor Versus Autologous Fecal Microbiota Transplantation for Irritable Bowel Syndrome

NCT04691544 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

The Effect of Dietary Supplementation on Intestinal Barrier Function in IBS-D

NCT06543498 ·Status: COMPLETED ·Phase: NA

Marine Protein Hydrolysate as Dietary Supplement in Irritable Bowel Syndrome

NCT03801057 ·Status: COMPLETED ·Phase: NA

Fecal Microbiota Transplantation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome

NCT02328547 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment

NCT02504060 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy of Open Label Placebo in Children With FGIDs

NCT02389998 ·Status: COMPLETED ·Phase: NA

A Pharmacy-based Study to Learn More About How Well Iberogast Works, How it Affects the Body, How it is Used, and User Satisfaction in Patients With Functional and Motility-related (Stomach and Bowel Movement-related) Gastrointestinal Diseases, Including Irritable Bowel Syndrome

NCT04993989 ·Status: COMPLETED

A Phase I, Randomized, Placebo-controlled, Double Blind, Repeat Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Gastrointestinal Transit Time and Pharmacodynamic Biomarkers of GSK3179106 in Normal Subjects

NCT02798991 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess the Efficacy and Safety of SKI3246 in Subjects With Non-Constipation Irritable Bowel Syndrome

NCT02079675 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Abdominal Distension by Biofeedback - a Randomized Controlled Trial

NCT01205100 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of Dietary Supplementation of Diamine Oxidase to Improve Symptoms in Patients With IBS

NCT06139744 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4